Kestra Private Wealth Services LLC Has $8.01 Million Holdings in Axon Enterprise, Inc (NASDAQ:AXON)

Kestra Private Wealth Services LLC raised its stake in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 5.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,227 shares of the biotechnology company's stock after acquiring an additional 807 shares during the quarter. Kestra Private Wealth Services LLC's holdings in Axon Enterprise were worth $8,009,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in AXON. Pinion Investment Advisors LLC lifted its holdings in Axon Enterprise by 3.0% in the first quarter. Pinion Investment Advisors LLC now owns 649 shares of the biotechnology company's stock valued at $341,000 after buying an additional 19 shares during the period. Kentucky Retirement Systems lifted its holdings in Axon Enterprise by 0.4% in the first quarter. Kentucky Retirement Systems now owns 4,953 shares of the biotechnology company's stock valued at $2,605,000 after buying an additional 19 shares during the period. WCM Investment Management LLC lifted its holdings in Axon Enterprise by 0.8% in the first quarter. WCM Investment Management LLC now owns 2,441 shares of the biotechnology company's stock valued at $1,306,000 after buying an additional 19 shares during the period. HBK Sorce Advisory LLC lifted its holdings in Axon Enterprise by 4.6% in the first quarter. HBK Sorce Advisory LLC now owns 451 shares of the biotechnology company's stock valued at $237,000 after buying an additional 20 shares during the period. Finally, Prudent Man Advisors LLC lifted its holdings in Axon Enterprise by 1.6% in the first quarter. Prudent Man Advisors LLC now owns 1,298 shares of the biotechnology company's stock valued at $683,000 after buying an additional 20 shares during the period. Institutional investors and hedge funds own 79.08% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on AXON shares. Morgan Stanley set a $885.00 price objective on shares of Axon Enterprise and gave the company an "overweight" rating in a report on Friday, July 11th. The Goldman Sachs Group increased their price objective on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a report on Wednesday, May 14th. UBS Group initiated coverage on shares of Axon Enterprise in a report on Wednesday. They set a "neutral" rating and a $820.00 price objective for the company. Needham & Company LLC boosted their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a report on Thursday, May 8th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Axon Enterprise from $730.00 to $850.00 and gave the company an "overweight" rating in a report on Thursday. One analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have issued a buy rating to the company's stock. According to data from MarketBeat.com, Axon Enterprise currently has an average rating of "Moderate Buy" and an average price target of $763.75.

Axon Enterprise Price Performance

NASDAQ:AXON opened at $756.09 on Friday. Axon Enterprise, Inc has a one year low of $279.02 and a one year high of $830.21. The company has a market cap of $58.86 billion, a P/E ratio of 182.63, a P/E/G ratio of 87.03 and a beta of 1.29. The firm's fifty day moving average price is $763.54 and its two-hundred day moving average price is $645.97. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.83 and a quick ratio of 2.62.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, beating the consensus estimate of $1.34 by $0.07. The business had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. Axon Enterprise's revenue was up 31.3% compared to the same quarter last year. During the same period in the prior year, the company posted $1.15 earnings per share. Equities analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Michael Garnreiter sold 5,913 shares of Axon Enterprise stock in a transaction that occurred on Wednesday, June 4th. The shares were sold at an average price of $760.00, for a total transaction of $4,493,880.00. Following the sale, the director directly owned 17,740 shares in the company, valued at $13,482,400. This trade represents a 25.00% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, President Joshua Isner sold 905 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, June 17th. The stock was sold at an average price of $776.39, for a total transaction of $702,632.95. Following the sale, the president owned 268,735 shares in the company, valued at approximately $208,643,166.65. This represents a 0.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 44,642 shares of company stock worth $30,500,428 in the last quarter. Corporate insiders own 4.40% of the company's stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.